Age, gender, and non-modulation - A sexual dimorphism in essential hypertension

The angiotensinogen gene is one of the very few related by linkage analysis to human hypertension, but the linkage has been consistently shown only among males. Moreover, polymorphisms in this gene predict an abnormal renal responsiveness to angiotensin II, a feature of non-modulation, but again, only among males. To pursue these related bridges between genetics and physiology, we evaluated the effects of sex on a second feature of non-modulation, the aldosterone response to infused angiotensin II during low sodium balance. We tested the resultant hypothesis-that non-modulation would be less frequent in women-by conducting identical protocols on 225 hypertensive inpatients (70 women, 155 men). Non-modulation was strikingly less frequent among women (26%; 95% confidence interval, 16% to 37%) than men (49%; 95% confidence interval, 40% to 57%) (P=.001). We tested the hypothesis that sex steroids play a role by comparing young, premenopausal women (<35 years) with women who were perimenopausal (45 to 55 years) and postmenopausal (>55 years). Among the youngest women, the frequency of nonmodulation was only 7%, significantly less than in young men (41%, P=.02). A steady increase in non-modulation frequency accompanied advancing age in women, reaching 47% in those older than 55 years, equal to the fraction of men affected. Age influenced non-modulation frequency in men far less. We conclude that a striking sex difference underlies the nonmodulation phenotype and that female sex hormones may confer protection against a genotypic predisposition in women. This ''override'' of genotype, manifest by a very low frequency of non-modulation in young women, may participate in their known protection against cardiovascular disease.